Risk stratification of hemophilia A patients
In a recent paper written with colleagues from the ABIRISK consortium we present a study of the genetic risk associated with inhibitor development in patients with severe hemophilia A. #ABIRISK #immunogenicity
https://www.ncbi.nlm.nih.gov/pubmed/31194850
